Scholarlink

<p>International travel is increasingly common, and it remains a clinical context in which preventable morbidity may occur if not adequately addressed through a comprehensive pre-travel consultation. This article provides a structured, evidence-informed framework for counseling people living with human immunodeficiency virus (HIV) who travel internationally, emphasizing the need for individualized assessment and proactive risk mitigation. We outline key domains relevant to travel health in people living with HIV, including legal and structural barriers, general health evaluation, vaccination planning, malaria prevention, sexual health, and strategies for managing expected and unexpected events during travel. Persistent HIV-related entry, stay, and residence restrictions in some countries may influence itinerary planning, disclosure, and access to healthcare abroad. From a clinical perspective, the cornerstone of safe travel is sustained viral suppression on antiretroviral therapy, with careful planning to ensure uninterrupted medication supply, adherence across time zones, and preparedness for loss or theft of medications. Drug-drug interactions are an important consideration, particularly when prescribing malaria chemoprophylaxis or antibiotics. Vaccination strategies should include routine and travel-specific immunizations, with attention to immune status, and the possibility of reduced immunogenicity requiring serological assessment or additional vaccine doses to obtain optimal response. Travel may increase sexual risk-taking and exposure to sexually transmitted infections (STIs), warranting targeted counseling on prevention, post-exposure strategies, and access to testing and treatment. Destination-specific precautions, such as malaria prevention, must combine rigorous mosquito avoidance measures with appropriate chemoprophylaxis compatible with antiretroviral therapy (ART) regimens. Overall, HIV-informed travel counseling should be considered a standard component of comprehensive HIV care, integrating medical, pharmacological, behavioral, and structural considerations to support safe travel and reduce avoidable complications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Traveling with HIV

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月23日

查看全文
  • Victor Daniel Miron,
  • Lorenzo Rabbi,
  • Sai Keertana Devarapalli,
  • Ana Fidji Glaría Campo,
  • Justyna Kowalska

摘要

International travel is increasingly common, and it remains a clinical context in which preventable morbidity may occur if not adequately addressed through a comprehensive pre-travel consultation. This article provides a structured, evidence-informed framework for counseling people living with human immunodeficiency virus (HIV) who travel internationally, emphasizing the need for individualized assessment and proactive risk mitigation. We outline key domains relevant to travel health in people living with HIV, including legal and structural barriers, general health evaluation, vaccination planning, malaria prevention, sexual health, and strategies for managing expected and unexpected events during travel. Persistent HIV-related entry, stay, and residence restrictions in some countries may influence itinerary planning, disclosure, and access to healthcare abroad. From a clinical perspective, the cornerstone of safe travel is sustained viral suppression on antiretroviral therapy, with careful planning to ensure uninterrupted medication supply, adherence across time zones, and preparedness for loss or theft of medications. Drug-drug interactions are an important consideration, particularly when prescribing malaria chemoprophylaxis or antibiotics. Vaccination strategies should include routine and travel-specific immunizations, with attention to immune status, and the possibility of reduced immunogenicity requiring serological assessment or additional vaccine doses to obtain optimal response. Travel may increase sexual risk-taking and exposure to sexually transmitted infections (STIs), warranting targeted counseling on prevention, post-exposure strategies, and access to testing and treatment. Destination-specific precautions, such as malaria prevention, must combine rigorous mosquito avoidance measures with appropriate chemoprophylaxis compatible with antiretroviral therapy (ART) regimens. Overall, HIV-informed travel counseling should be considered a standard component of comprehensive HIV care, integrating medical, pharmacological, behavioral, and structural considerations to support safe travel and reduce avoidable complications.